AU627944B2 - Rna having endonuclease and antisense activity, the preparation thereof and the use thereof - Google Patents

Rna having endonuclease and antisense activity, the preparation thereof and the use thereof Download PDF

Info

Publication number
AU627944B2
AU627944B2 AU64995/90A AU6499590A AU627944B2 AU 627944 B2 AU627944 B2 AU 627944B2 AU 64995/90 A AU64995/90 A AU 64995/90A AU 6499590 A AU6499590 A AU 6499590A AU 627944 B2 AU627944 B2 AU 627944B2
Authority
AU
Australia
Prior art keywords
rna
plants
gene
ribozyme
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU64995/90A
Other versions
AU627944C (en
AU6499590A (en
Inventor
Peter Eckes
Hubert Mullner
Rudolf Schneider
Eugen Uhlmann
Bernadus Uijtewaal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of AU6499590A publication Critical patent/AU6499590A/en
Application granted granted Critical
Publication of AU627944B2 publication Critical patent/AU627944B2/en
Publication of AU627944C publication Critical patent/AU627944C/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8283Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for virus resistance
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/11Antisense
    • C12N2310/111Antisense spanning the whole gene, or a large part of it
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/12Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C12N2310/121Hammerhead

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Host cells can be transformed so that they express ribozyme RNA and antisense RNA, which are linked together in the loop of the ribozyme. The RNA molecules can, for example, be complementary to a particular viral RNA. Plants transformed with genes coding for such RNA display significantly improved defences against viruses.

Description

C 7 9 4 AMMONVEALTH OF AUSTRALIA PATENTS ACT 1952-69 COMPLETE SPECIFICATION
(ORIGINAL)
Class In Application Number: Lodged: 0 1 Form t. Class a Qlomplete Specification Lodged:
CCC
.Pririt Accepted: Published: Related Art: N \ame of Applicant ,dcress of Applicant Actual Inventor Address for Service HOECHST AKTIENGESELLSL, 50 Bruningstrasse, D-6230 Frankfurt/Main of Germany 80, Federal Republic HUBERT MULLNER, RUDEOLF SCHNEIDER, EUGEN UHLMANN, BERNADUS U1 JTEWAAL and PETER ECKES WATERMARK PATENT TRADEMARK ATTORNEYS.
LOCKED BAG NO. 5, HAWTHORN, VICTORIA 3122, AUSTRALIA Complete Specification for the invention entitled: RNA HAVING ENEONUCLEASE AND ANTISENSE ACTIVITY, THE PREPARATION THEREOF AND THE USE THEREOF The following statement is a full description of this invention, including the best method of performing it known to :-us i
~Y
HOECHST AKTIENGESELLSCHAFT HOE 89/F 348 Dr. iH/gm Description RNA having endonuclease and antisense activity, the preparation thereof and the use thereof RNA molecules can, under suitable conditions, catalyze reactions on other RNA molecules or autocatalytically o" cleave fragments from their own molecules without the a participation of proteins. Thus an intron having 413 o 5 nucleotides is autocatalyically deleted from the 3' end a of the 23S rRNA of Tetrahymena thermophila and converted 00" into circular form. This takes place by a number of s, phosphoester-transfer reactions with the participation of guanosine cofactors (Cech, Nature 30, 578-583 (1983)). Depending on the RNA substrate or the reaction conditions chosen, the intron can function as specific 1 ribonuclease, terminal transferase, phosphotransferase or acid phosphatase. In this connection an RNA molecule can carry out several reactions without being changed itself 15 and, in this respect, behave like an enzyme. For this reason the term ribozyme has bee.. coined for RNA molecules having these properties.
9, It has also been possible to show similar reactions without the participation of proteins for some viroid RNAs and satellite RNAs. Thus self-processing seems to be a reaction essential for the multiplication for avocado sunblotch viroid (ASBV) ,chins, C.J. et al. Nucleic Acids Res. 14, 3627-3640 (1986)), satellite RNA of tobacco ringspot virus (sTobRV) (Prody, G.A. et al., Science 231, 1577-1580 (1986)) and satellite RNA of lucerne transient streak virus (sLTSV) (Forster A.C. et al., Cell 49, 211-220 (1987)). During the replication of these RNAs, circular forms which, as templates, lead to the synthesis of RNAs with extensions are presumably formed. These transcripts are cut to the right genomic length by the autocatalytic endonucleolytic reactions.
r_ i 2 The structures of the RNAs which the latter presumably assume for the reaction have been described as "hammerheads" (Forster A.C. et al., Cell 49, 211-220 (1987); Haseloff, J. et al., Nature 334, 585-591 (1988)).
The cleavage sites for these RNA enzymes are specific and have to have certain structural characteristics so that processing can take place.
It has now been found that host cells or any desired organism can be transformed using vectors which contain 10 DNA coding for ribozymes coupled to antisense RNA, so that the said RNA is expressed.
«I
It is known that antisense RNA inhibits gene expression in a number of prokaryotic and eukaryotic cells, inter alia also in plant cells (Green, pt Il., Ann. Res.
Biochem. 55, 569 (1986)). The mechanism ot inhibition is still largely unclear. It is presumed that doublestranded RNA which interferes with the transport of the mRNA to the cytoplasm is formed in eukaryotic systems.
Rezaian, M. et al., Plant Mol. Biol. 11, 463 (1988) investigated, for example, the possibility of using antisense RNA as antiviral agent against cucumber mosaic S: virus (CMV). However, ths authors observed that the antiviral activity of the antisense RNA was unsatis- Sfactory.
S 25 However, the coupling of the appropriate ribozyme RNA in i the loop (see below for diagram) with an appropriate antisense RNA now results in a more effective resistance to viruses than Rezaian was able to show. Such a coupling of the RNA molecules thus effects an increased activity, which is directed against a substrate, in transformed organisms not only in relation to the activity as antiviral agent in plants but also in general.
i i 3 The invention thus relates to: 1. A gene coding for a ribozyme RNA sequence in the loop coupled with a antisense RNA sequence.
2. Host cells which contain the gene defined under 1.
3. The use of the RNA encoded by the gene defined under 1. as an agent, which is directed against a substrate, in host cells.
The invention will be described in detail below, in particular in its preferred embodiments. The invention is .o 10 furthermore defined by the contents of the claims.
o 0 The ribozyme/antisense RNA can be directed against substrates such as, for example, RNA coding for selectable marker genes (resistance to antibiotics) or RNA 00 coding for any desired cell functions, such as, for example, dihydrofolate reductase, thymidine kinase, the ripening enzymes polygalacturonase, pectin esterase etc., proteins responsible for differentiation and development, or hormone receptors. In particular types of viruses which are harmful to plants can be combated advant- 20 ageously by the system according to the invention. For S*,this purpose the procedure described below is used, for example. A ribozyme/antisense RNA which is directed against other substrates can also be constructed in an analogous way.
S 25 The ribozyme moiety can be synthesized on the basis of the RNA sequence of the substrate to be inhibited. In the case of a virus as substrate, this RNA sequence is either the genome of RNA viruses or an RNA sequence which has been derived from the DNA sequence of a DNA virus. Any virus harmful to plants can therefore be used as basis.
Preferred types of viruses are pathogenic viruses, in particular cucumber mosaic virus, brome mosaic virus, alfalfa mosaic virus, tobacco mosaic virus, potato virus t i i~ irr~-- '~sc 4 X or Y, tomato ringspot virus, tomato aspermy virus or tobacco rattle virus. In particular the RNA sequences RNA1, RNA2 and/or RNA3 of cucumber mosaic virus are used as template, corresponding to the sequence from the publications by Rezaian, M. et al. Eur. J, Biochem. 150, 331 (1985), Eur. J. Biochem. 143, 277 (1989) and Gould, J. et al., Eur. J. Biochem. 126, 217, (1982) or in each case parts therefrom. At least 10 consecutive nucleotides, in particular 14 to 20 nucleotides, advanto 10 ageously selected from the middle of the RNA sequence of the appropriate virus, are preferred for the synthesis.
o ~The ribozyme-encoding oligonucleotides are synthesized in such a way that the initial and terminal sequences which, o' in each case, consist of at least 5 nucleotides, advantageously 7 to 10 nucleotides, are complementary to the RNA of the virus to be inhibited. The intermediate sequence consists in part of specific nucleotides which are predetermined for the functioning of the ribozyme, Sand in part of variable nucleotides.
0 J 4 Corresponding procedures are used for the preparation of the antisense RNA but the oligonucleotides are synthesized in such a way that they code for an RNA in the appropriate antisense orientation.
The ribozyme oligonucleotide is provided with an appropriate linker in the loop. Linkers of this kind have, for example, cleavage sites of EcoRI, SalI, BamHI, HindIII, EcoRV, SmaI, XhoI, KpnI, preferably XbaI or PstI. The synthesized ribozyme oligonucleotide is then coupled via these linkers to the oligonucleotide coding for the antisense RNA in the ribozyme loop.
The ribozyme/antisense RNA system hybridized with substrate RNA may be represented diagrammatically as follows: L -i II i b0 U 40) o o4 0 03 00 40 4 04u40 5 NNNNNNNNNNNNNN-3 substrate RNA 3-KKKKKKKKCA
AC
A U GA
G
CG G V ribozyme
VV
VV
V, \V where N are nucleotides of the substrate RNA, A, C, G or T, K are nucleotides complementary to N in the ribozyme, V are variable nucleotides in the ribozyme and V, are variable nucleotides in the loop of the ribozyme. The number of v, nucleotides can be 0-550. V
L
nucleotides are chosen such that a cleavage site into which the sequences can be inserted is produced at the DNA level.
The assembled oligonucleotides are cloned with the aid of the vectors pUC19, pUC18 or pBluescript (Stratagene, Heidelberg, Product Information) and sequenced.
a 4 4, 0l 4 The confirmed oligonucleotide is cloned into an intera" mediary vector having a plant promoter. Vectors of this 04 1I type are, for example, the plasmids pPCV701 (Velten J. et al., EMBO J. 3, 2723-2730 (1984)), pNCN (Fromm H. et al.
PNAS 82, 5824-5826 (1985)) or pNOS (An, G. et al., EMBO J. 4, 277-276 (1985)). The vector pDH51 (Pietrzak, M. et al., NAR 14, 5857, (1986)) which has a 35S promoter is preferably used.
After subsequent transformation of E. coli, such as, for example, E. coli MC 1061, DH1, DK1, GM48 or XL-1, positive clones are identified by methods known per se (Maniatis et al., Lab. Manual), such as plasmid minipreparations and cleavage with an appropriate restriction enzyme.
OIL-
6 These positive clones are then subcloned into a binary plant vector. As plant vectors, pGV3850 (Zambrysk, P. et al., EMBO J. 2, 2143-2150 (1983)) or pOCA18 (Olszewski, NAR 16, 10765-10782, (1988)) can be employed. Advantageously pOCA18 is used.
The resulting binary plant vectors which contain a plant promoter with the attached DNA fragment for the ribozyme production in the T-DNA are used to transform plants.
This can be carried out by techniques such as electroii1 poration or microinjection.
4 0 4 The cocultivation of protoplasts or the transformation of leaf pieces using agrobacteria is preferably employed.
o *e For this purpose the plant vector construct is transferred by transformation with purified DNA or, mediated by a helper strain such as E. coli SM10 (Simon R. et al., Biotechnology 1, 784-791 (1983)), into Agrobakterium S- tumefaciens, such as A282, having a Ti plasmid via a *triparental mating. Direct transformation and triparental imating were carried out as described in "Plant Molecular Biology Manual" (Kluwer Academic Publishers, Dordrecht (1988)).
i s i In principle, all plants can be transformed by the binary plant vectors carrying the DNA constructed according to the invention. Dicotyledonous plants, in particular useful plants, which produce or store starch, other carbohydrates, proteins or fats in usable amounts in their organs or which produce fruit and vegetables or i supply spices, fibers and technically usable products or medicaments, dyes or waxes, and also fodder plants.
Examples which may be mentioned are tomato, strawberry, avocado, and plants which carry tropical fruit, for example papaya, mango, but also pear, apple, nectarine, apricot or peach. Furthermore, examples which may be listed as plants to be transformed, are all types of cereal, rape, turnip rape, potatoes, soybean, cotton, corn, sugarbeet or sunflowers. The transformed cells are j i..
7 selected for with the aid of a selection medium, are cultured to a callus and regenerated to the plant on an appropriate medium (Shain et al., Theor. appl. Genet. 72, 770-770 (1986); Masson, J. et al., Plant Science 53, 167- 176 (1987), Zhan et al., Plant Mol. Biol. 11, 551-559 (1988); McGranaham et al., Bio/Technology 6, 800-804 (1988) Novrate et al., Bio/Technology 2, 154-159 (1989).
00 0 40*"10 00 0 0000 0 00 00 0 00Q O 0~ 4' 44 4 44 d2 The resulting plant is changed by the transformation in such a way that, with the aid of the constructed oligonucleotides, the corresponding RNA is expressed in the cells, it being possible that ribozyme RNA together with "antisense" RNA becomes active against virus RNA.
The examples which follow are intended to illustrate the invention further.
Examples Percentages relate to the weight if not stated otherwise.
1. Synthesis of the DNA for the expression of RNA The synthesis of the nucleotide for the ribozyme was carried out on the basis of the CMV RNA1 sequence, position 3248 to 3264, (Rezaian M. et al., Eur. J.
Biochem 150, 331-339 (1985)) provided with an XbaI linker on the 5' end and a PstI linker on the 3' end. The constant regions are evident from the attached diagram for the ribozyme: DNA for the expression of a ribozyme with an Sal site in the variable part of the loop: 5'-CTAGAGGTACCTCCTGATGAGTCGTCGACGACGAAACAACCTTCTGCA-3'
TCCATCGAGGACTACTCAGCAGCTGCTGCTTTGTTGGAAG
r_ 1 -8-
-CTAGATTTCAAGGGTAGCTCCTGATGAGTCGTC
3' TAAAGTTCCCATGGAGGACTACTCAGGAG 3' CTGCTGCTTTGTTGGAACATCCTACAG -51 1 0 0 000 000 0 000 0 4 0'0 0 too o 0 0 00 000 000 0 on 0 00 0 0 0 The synthesis of the nucleotide for the antisense RNA was carried out on the basis of the CMV RNA4 sequence (Gould I. et al., Eur. J. Biochem. 126, 217-26 (1982)) from position 2179 to 2193 with an XbaI linker on the 5' end and with a PstI linker on the 3' end, which were filled in order to create a Sai site for cloning.
DNA for the production of an antisense RNA: 5- C:ACATGGTCTCCTTATGGAGAACCTGTGGAAAACCACAGCTGCA- 3
?A.CCAGAGGAATACCTCTTGGACACCTTTTGGTGTCG
or.
T.C5A.CA TGGTCTC CTTATGGAGAACCTGTGGAAAACCACAGcG- 3' RG CT 00000 0 0 2. Cloning in pBluescript SK+ and sequencing The plasmid pBluescript SK+ (Stratagene, Product Information) was cut open with the particular enzymes and, after treatment with calf intestinal phosphatase (CIP), was ligated with a five-fold excess of the double-stranded, phosphorylated oligonucleotides. After induction with isopropylgalactoside (IPTG) it was possible to identify positive clones in the strain XL Blue (Stratagene) as white colonies on plates containing 5-bromo-4-chloro-3indolyl ,p-D-galactoside (X-gal)l.
of the colonies were isolated in each case and sequenced by the dideoxy method (Boehringer, Sequencing kit), in order to determine the orientation of the inserted oligonucleotide..
9 4o P a a a aa 0 0t10 aaP PC CO ftp a 4 4 0) ap a s Pa 0 a o9 0 0 4G 4 Fig. 1: pBluescript SK clones containing the desired oligonucleotide DNA after digestion with Xba/Pst.
3. Cloning in pDH51 The plasmid pDH51 is reproducibly described in the publication Pietrzak, M. et al., NAR 14, 5857-5868, 1986.
The plasmid pBluescript SK+ containing the oligonucleotide was digested with XbaI and PstI in order to be able to isolate the oligonucleotide DNA after the fragment fractionation in a 1% low melting agarose gel.
The isolated oligonucleotide was incorporated into the Xba/Pst site of pDH51 in a five-fold excess. It was possible to detect positive clones, after the transformation of E. coli MC 1061 cells and transfer of the colonies onto nitrocellulose filters, by hybridization with 32 P-labeled oligonucleotide DNA and subsequent washing of the filters in SSC 1 x SSC; 2. 0.1 x SSC; 3. 0.1 x SSC for 30 min each time) at A DNA sequence for the synthesis of the antisense oligonucleotide DNA was via the newly created SalI cleavage site cloned into a vector generated in this way.
L i, I r I 1 i i 10 Fig. 2:.
After the transformation of E. coli MC 1061 cells, the colonies were streaked onto nitrocellulose filters and hybridized overnight with 32 P-labeled oligonucleotide DNA which was isolated from an appropriate pE-iescript SK+.
The filters were washed as mentioned above. The autoradiography was carried out overnight.
i0 tion Olszewski, N. et al., NAR 16, 10765-10782, 1988. The about 1.0 kb long EcoRI fragment from pDH51 with the oligonucleotide after the 35S promoter was isolated on a CsCl gradient, and the 9.8 kb fragment resulting from EcoRI digestion was incorporated into the EcoRI cleavage site of pOCA18.
The positive clones were identified by means of a DNA preparation and a subsequent EcoRI step.
I
11 I ae 14 i 4 00 'il Fig. 3: Lane 1 2: Lane 3: Fig. 4: Lane 1 3: Lane 2 4: Clones cut with EcoRI after the CsCl purification x DNA cut with EcoRI/HindIII
I,
414 1 4 4 4 1 DNA cut with EcoRI, from the ligase reaction of vector pOCA18 with the 0.8 kb fragment As above, but uncut 5. Transformation of agrobacteria The vector pOCA18 containing the 35S promoter/oligonucleotide insert was transferred into the agrobacterial strain A282 (Pharmacia, Freiburg, FR Germany or ATCC 37349 USA). This was carried out by a triparental mating with the aid of the E. coli strain SM10 (Simon, R. et al., Bio/Technology 1, 784-791, 1983). For this purpose equal amounts of the bacteria were placed together on a filter overnight, incubated at 28°C, and the filters were rinsed with 2 ml of 10 mM MgSO, and aliquots thereof were placed on yeast extract containing tetracycline and I II-' 12 rifampicin (YEB: 1% yeast extract, 1% peptone, 0.5% NaCI) in order to select for positive clones. The subsequent h'-bridization of the colonies, which had been transferred onto nitrocellulose membranes, with radiolabeled oligonucleotide DNA again demonstrated the presence of positive clones.
4 S Fig. 5: Transformed agrobacteria were streaked onto filters, incubated at 28°C overnight and hybridized with radio- 4 i 4 .0 labeled oligonucleotide DNA.
6. Transformation of tobacco The agrobacteria were grown in YEB medium containing tetracycline and rifampicin. 20 ml of the bacteria were spun down, washed once in YEB medium and, suspended in 20 ml of 10 mM MgSO, placed in a Petri dish. The plant material used was Nicotiana tabacum Wisconsin 38. The plants had been cultivated for 4 weeks under sterils conditions on 2MS medium (Murashige, T. et al., Physiol.
Plant 15, 473-497 (1962)) at 25*°C with 16 h of light per day. A 1 cm 2 leaf piece was cut off these plants, damaged with sterile emery paper and immersed in the overnight lbld lgnceoieDA 6. Tasfraio ftoac The agoatrawr rw i E eimcnann tercciean ianii. 0m fte atrawr spu don wahdoc nYBmdu nsseddi 20I mlo 0 MMSpae i erids.Th ln -e ~~iiii~i%:i~rji 13 bacterial culture for 30 sec.
The leaf pieces were, as described above for 2 MS, maintained on MS medium for 2 days at 25°C and then washed with liquid 2MS medium. Then these leaf pieces were placed on MSC 10 plates (MS medium containing agar) containing kanamycin. After 5-6 weeks, it was possible to replant regenerated plants into larger vessels where they formed roots after 2-3 weeks.
t m SThe expression of the desired RNA in the transgenic o 0 plants was detected by transferring the total RNA t oi (10 pg), which had been fractionated in a gel agarose ao gel containing 2.2 M formaldehyde), onto nitrocellulose filters and subsequent hybridization with radioactive oligonucleotide DNA.
p x I I I I Fig. 6: Lane 1: 10 yg of total RNA of the control plant were, after fractionation in a gel,
~C
4 t 14 transferred onto nitrocellulose. The hybridization was carried out with radiolabeled oligonucleotide DNA.
As above, but 10 pg of total RNA of the transgenic plants were applied in each Lane 2 24: case.
7. Detection of the transformation I a DNA was isolated from about 8-week old transformed 9o i tobacr.o plants by standard methods (Maniatis et al., Lab.
Journal) and cut with EcoRI, and 10 pg of DNA were transferred onto nitrocellulose membranes in each case and hybridized with 3 2 P-labeled oligonucleotide DNA. The incorporation of the desired sequence in the DNA of the transgenic plant was detectable by hybridization with the characteristic EcoRI DNA.
t C ttll Fig. 7: Lane 1-9: 10 pg of total DNA of transgenic plants were, in each case, hybridized with radiolabeled oligonucleotide DNA on nitrocellulose.
Lane 10: As above, but total DNA of the control plant.
i II i I i, i; 15 8. Detection of the expression of the RNA RNA was isolated from a second leaf sample from the abovementioned tobacco plants, transferred onto nitrocellulose from a formaldehyde gel and hybridized as above. It was possible to detect bands which showed the expected sizes.
i t I
I,
150~ 1 S: SI I S S 9. Detection of the in vitro activity of the multifunctional RNA RNA was produced from the pBluescript SK+ clones containing the inserted entire oligo by addition of T3 or T7 polymerase in a reaction mixture (Stratagene, Product Information for SK+) and then isolated. Hybridization of this RNA with 32 P-labeled CMV RNA showed a cleavage of the virus RNA.
10. Infection with CMV strain Q About 8-week old tobacco plants were infected, with the aid of carborundum, with the CMV strain Q (Rezaian, M. et al., Eur. J. Biochem. 150, 331 (1985); 143, 277 (1984); Gould, J. et al., Eur. J. Biochem. 126, 217 (1982)).
Control plants showed distinct symptoms after 12-15 days.
It was possible to detect virus particles in these plants. The transgenic plants proved to be resistant to the virus to varying degrees.
15 c, i~Wlul~-iu*-~ ~isssP l1 lrrr~aarra~?lrmam~naraY~~i* r-r iir.:l v i 16 Table: Percentage of infected plants with distinct symptoms after the time stated in each case plants of a clone were infected together and evaluated, in each case) 12 d 20 d Wild type W, 38 iOI I I I IP I ast 4*1 1 Ie I
I
ldCll Transgenic plants Clone Numbers: 3 7 L i- i I r

Claims (6)

1. A gene coding for a ribozyme RNA sequence in the loop coupled to a antisense RNA sequence.
2. The gene as claimed in claim 1, with the encoded RNA being complementary to a virus RNA. S 3. An RNA 3ncoded by a gene as claimed in claim 1 or 2. "fo 4. A host cell containing a gene as claimed in one of claims 1 or 2. A host cell containing an RNA as claimed in claim 3.
6. Plants, plant cells and parts or seeds of the plants, containing the gene as claimed in claim 1 or 2.
7. Plants, plant cells and parts or seeds of the plants, containing the RNA as claimed in claim 3.
8. The use of the RNA encoded by the gene as claimed in S' claim 1 as agent directed against the substrate, in host cells.
9. The use of the RNA encoded by the gene as claimed in claim 2 as antiviral agent. DATED this 23rd day of October 1990. HOECHST AKTIENGESELLSCHAFT WATERMARK PATENT TRADEMARK ATTORNEYS "THE ATRIUM" 290 BURWOOD ROAD HAWTHORN. VIC. 3122.
AU64995/90A 1989-10-25 1990-10-25 RNA having endonuclease and antisense activity, the preparation thereof and the use thereof Ceased AU627944C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3935473A DE3935473A1 (en) 1989-10-25 1989-10-25 RNA WITH ENDONUCLEASE AND ANTISENSE ACTIVITY, THEIR PRODUCTION AND THEIR USE
DE3935473 1989-10-25

Publications (3)

Publication Number Publication Date
AU6499590A AU6499590A (en) 1991-05-02
AU627944B2 true AU627944B2 (en) 1992-09-03
AU627944C AU627944C (en) 1992-10-22

Family

ID=

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU634289B2 (en) * 1989-10-06 1993-02-18 Hoechst Aktiengesellschaft A multifunctional rna having self-processing activity, the preparation thereof and the use thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6218690A (en) * 1989-09-07 1991-03-14 Hoechst Aktiengesellschaft Rna with endoribonuclease activity for mrna of ripening genes, the preparation thereof and the use thereof in plants
AU6282790A (en) * 1989-09-05 1991-04-08 Fabaro Pty Limited Portable light socket dimmer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6282790A (en) * 1989-09-05 1991-04-08 Fabaro Pty Limited Portable light socket dimmer
AU6218690A (en) * 1989-09-07 1991-03-14 Hoechst Aktiengesellschaft Rna with endoribonuclease activity for mrna of ripening genes, the preparation thereof and the use thereof in plants

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU634289B2 (en) * 1989-10-06 1993-02-18 Hoechst Aktiengesellschaft A multifunctional rna having self-processing activity, the preparation thereof and the use thereof

Also Published As

Publication number Publication date
EP0428881A1 (en) 1991-05-29
HU906538D0 (en) 1991-04-29
EP0428881B1 (en) 1995-06-28
DE3935473A1 (en) 1991-05-02
IE67653B1 (en) 1996-04-17
NZ235789A (en) 1992-07-28
AU6499590A (en) 1991-05-02
DE59009334D1 (en) 1995-08-03
IE903825A1 (en) 1991-05-08
HUT58794A (en) 1992-03-30
DK0428881T3 (en) 1995-10-30
JPH044877A (en) 1992-01-09
ES2076275T3 (en) 1995-11-01
KR910008136A (en) 1991-05-30
ATE124450T1 (en) 1995-07-15

Similar Documents

Publication Publication Date Title
Leiser et al. Agroinfection as an alternative to insects for infecting plants with beet western yellows luteovirus.
US5834265A (en) Multifunctional RNA having self-processing activity, the preparation thereof and the use thereof
EP3214177A2 (en) Methods and means for obtaining modified phenotypes
KR20010112952A (en) Regulation of viral gene expression
US20080104732A1 (en) Methods and means for obtaining modified phenotypes
NZ516929A (en) Methods for reducing the phenotypic expression of a nucleic acid of interest in plant cells, by providing aberrant, preferably unpolyadenylated, target-specific RNA to the nucleus of the host cell
KR20010041943A (en) Genes encoding MLO proteins and conferring fungal resistance upon plants
Nelson et al. Tobacco mosaic virus infection of transgenic Nicotiana tabacum plants is inhibited by antisense constructs directed at the 5′ region of viral RNA
CA2095109C (en) Process for production of exogenous gene or its product in plant cells
US5519164A (en) Expression of a multigene RNA having self-splicing activity
IE903825A1 (en) RNA having endonuclease and antisense activity, the preparation thereof and the use thereof
Han et al. Ribozyme-mediated resistance to rice dwarf virus and the transgene silencing in the progeny of transgenic rice plants
US7230089B1 (en) Methods for increasing plant cell proliferation by functionally inhibiting a plant cyclin inhibitor gene
US5633434A (en) Transgenic plants displaying virus and phosphinothricin resistance
HU223266B1 (en) Method for inducing viral resistance into a plant
KR100240356B1 (en) Expression of a multigene rna with self-splicing activity
AU763298B2 (en) Ribozymes capable of conferring resistance to potyvirus infection, and plants expressing said ribozymes
Hille et al. Genetic transformation of tomato and prospects for gene transfer
MXPA00005493A (en) Ribozymes capable of conferring resistance to potyvirus infection, and plants expressing said ribozymes
JP2003334087A (en) Promoter originated from plant virus
WO2002083886A2 (en) Means and method for the preparation of transgenic plants resistant to viral infections
WO2002050281A1 (en) Virus resistance in plants

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired